Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Urothelial Cell Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT06862219
What this trial is testing

A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer

Who this might be right for
Metastatic Urothelial Carcinoma
Astellas Pharma Global Development, Inc. 100
Early research (Phase 1)Ended earlyNCT05233436
What this trial is testing

PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorsGastric CancerGastroesophageal Junction Cancer+3 more
Pfizer 21
Testing effectiveness (Phase 2)Ended earlyNCT03272217
What this trial is testing

Atezolizumab With Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
Arjun Balar, MD 16
Testing effectiveness (Phase 2)WithdrawnNCT03935347
What this trial is testing

Adoptive Cell Therapy With (LN-145) in Combination With Pembrolizumab in Treating Patients With Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy

Who this might be right for
Metastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis Urothelial CarcinomaMetastatic Ureter Urothelial Carcinoma+3 more
Roswell Park Cancer Institute
Not applicableStudy completedNCT07386847
What this trial is testing

A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer

Who this might be right for
Metastatic Urothelial CarcinomaUrothelial CancerUrothelial Carcinoma+1 more
Pfizer 1
Large-scale testing (Phase 3)WithdrawnNCT04568304
What this trial is testing

A Study Evaluating Toripalimab Injection Combined With Standard Chemotherapy as a First-line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Locally Advanced or Metastatic Urothelial Carcinoma
Shanghai Junshi Bioscience Co., Ltd.
Testing effectiveness (Phase 2)Study completedNCT02872714
What this trial is testing

Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)

Who this might be right for
UC (Urothelial Cancer)
Incyte Corporation 263
Large-scale testing (Phase 3)Study completedNCT03410693
What this trial is testing

Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Carcinoma, Transitional Cell
Bayer 175
Not applicableApproved For MarketingNCT02589717
What this trial is testing

An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy

Who this might be right for
Urothelial Carcinoma
Genentech, Inc.
Early research (Phase 1)Looking for participantsNCT06439836
What this trial is testing

Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy

Who this might be right for
Metastatic Urothelial CarcinomaUnresectable Urothelial Carcinoma
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Ended earlyNCT01094496
What this trial is testing

The CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study)

Who this might be right for
Bladder Cancer
Celldex Therapeutics 3
Testing effectiveness (Phase 2)Looking for participantsNCT06405425
What this trial is testing

BL-B01D1 + PD-1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 52
Early research (Phase 1)Study completedNCT02989064
What this trial is testing

MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers

Who this might be right for
Urothelial CarcinomaHead and Neck CancerMelanoma+1 more
Adaptimmune 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03473743
What this trial is testing

Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
Janssen Research & Development, LLC 125
Testing effectiveness (Phase 2)Ended earlyNCT02693717
What this trial is testing

Pemetrexed Disodium in Treating Patients With Previously Treated Metastatic Urothelial Cancer

Who this might be right for
Metastatic Urothelial Carcinoma
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT05327530
What this trial is testing

The Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)

Who this might be right for
Locally Advanced or Metastatic Urothelial Carcinoma
EMD Serono Research & Development Institute, Inc. 256
Early research (Phase 1)Study completedNCT03758781
What this trial is testing

IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors

Who this might be right for
Metastatic CancerRecurrent CancerSolid Tumor+6 more
H. Lee Moffitt Cancer Center and Research Institute 12
Testing effectiveness (Phase 2)Ended earlyNCT03277352
What this trial is testing

INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07837622
What this trial is testing

BL-M09D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors

Who this might be right for
Urothelial Carcinoma (UC)Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 42
Early research (Phase 1)Ended earlyNCT04628780
What this trial is testing

Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors

Who this might be right for
Non-small-cell Lung CancerSquamous Cell Carcinoma of the Head and NeckRenal Cell Carcinoma+3 more
Pfizer 37
Next Page